BKUH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BKUH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Bakhu Holdings's Pre-Tax Income for the three months ended in Apr. 2024 was $-0.91 Mil. Bakhu Holdings's Revenue for the three months ended in Apr. 2024 was $0.00 Mil. Therefore, Bakhu Holdings's pretax margin for the quarter that ended in Apr. 2024 was %.
The historical rank and industry rank for Bakhu Holdings's Pretax Margin % or its related term are showing as below:
The historical data trend for Bakhu Holdings's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bakhu Holdings Annual Data | |||||||||||||||||||||
Trend | Jul08 | Jul09 | Jul10 | Jul17 | Jul18 | Jul19 | Jul20 | Jul21 | Jul22 | Jul23 | |||||||||||
Pretax Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Bakhu Holdings Quarterly Data | ||||||||||||||||||||
Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | |
Pretax Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Drug Manufacturers - Specialty & Generic subindustry, Bakhu Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bakhu Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Bakhu Holdings's Pretax Margin % falls into.
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Bakhu Holdings's Pretax Margin for the fiscal year that ended in Jul. 2023 is calculated as
Pretax Margin | = | Pre-Tax Income (A: Jul. 2023 ) | / | Revenue (A: Jul. 2023 ) |
= | -10.305 | / | 0 | |
= | % |
Bakhu Holdings's Pretax Margin for the quarter that ended in Apr. 2024 is calculated as
Pretax Margin | = | Pre-Tax Income (Q: Apr. 2024 ) | / | Revenue (Q: Apr. 2024 ) |
= | -0.907 | / | 0 | |
= | % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bakhu Holdings (OTCPK:BKUH) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Thank you for viewing the detailed overview of Bakhu Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Tom Vaknin | director | SPYROU KYPRIANOU 16, PYGROS / LIMMASOL G4 4529 |
Moshe Morgenstern | director | MENACHEM BEGIN 88, PETAH TIKVAH/CENTRAL DISTRICT L3 49504 |
Geoffrey Robert Dixon | 10 percent owner | 16 SHOBY LANE, GRIMSTON X0 LE14 3DD |
Michael Richard Hawthorne | officer: Deputy CEO | 20 LARKSBOROUGH AVENUE, COUNTY DOWN X0 BT23 8SU |
Garcia La Sienra Garcia Juan Carlos | director, officer: CFO | 3 SHANEWOOD CT, THE WOODLANDS TX 77382 |
Sagi Rami Rozen | director | HOUSE NUMBER 8, 8 AGIAS TRIADAS STREET (MOUTTAGIAKA), LIMASSOL G4 4527 |
Cell Science Holding, Ltd. | 10 percent owner | PANTELI KATELARI 18A, AGIOS IOANNIS, LIMASSOL G4 3012 |
Mentone, Ltd. | 10 percent owner | 3 COPLOW CRESCENT, SYSTON, LEICESTER X0 LE7 2JE |
Inter-m Traders Fz, Lle | 10 percent owner | 18A PENTELI KATELARI, LIMASSOL G4 3021 |
Thomas K Emmitt | director, officer: President, CEO and Secretary | ONE WORLD TRADE CENTER, SUITE 130, LONG BEACH CA 90831 |
Aristotle Popolizio | director | 206 PASSAIC AVENUE, ROSELAND NJ 07068 |
Evripides Drakos | director | 139C GLOUCESTER TERRACE, LANCASTER GATE, LONDON X0 W2 6DX |
Peter Whitton | director | 3 COPLOW CRESCENT, SYSTON LEICESTER X0 LE7 2JE |
Oz Corp | 10 percent owner | 24328 VERMONT AVENUE, SUITE 300, HARBOR CITY CA 90710 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 03-09-2022
By ACCESSWIRE ACCESSWIRE • 02-15-2023
By ACCESSWIRE ACCESSWIRE • 04-06-2022
By ACCESSWIRE ACCESSWIRE • 08-17-2022
By ACCESSWIRE ACCESSWIRE • 09-20-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.